Cavendish Global announced today the selection of accomplished leaders of private-equity firms from the United States and the United Kingdom to participate in the Cavendish Global Health Impact Forum taking place Monday, November 10th to Thursday, November 13th at Oxford University in the United Kingdom. The selected private-equity firms and the partners representing them includes:
- Mr. Michael Greeley, General Partner, Foundation Medical Partners of Boston, Massachusetts
- Mr. John H. Friedman, Founding and Managing Partner, Easton Capital of New York
- Mr. Edward Mott, Founding Partner, Oxford Capital Partners of Oxford, England
- Mr. Bruce Roberts, Co-Founder and Managing Director, of Roberts Mitani and Health Family Capital of New York
- Andrew Schiff, M.D., Managing Director, Aisling Capital of New York
These respected leaders from the world of private-equity will participate in a panel discussion to share how they identify innovations with the potential for transformational impact on health and the life sciences together with how to make sure compelling companies are successfully financed, developed and commercialized.
The purpose of the by-invitation Forum is to help family offices and foundations develop and implement their individual impact investing and grant-giving programs within health and the life sciences. To accomplish this mission the Forum showcases presentations and panel discussions by leading scientists, accomplished healthcare delivery professionals, private-sector companies and institutional investors engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment.
Michael Moffat, Cavendish co-founder and President said, "This is an exceptionally talented group of institutional investors with a well-developed knowledge of what it takes to successfully innovate in the life sciences. Collectively they have managed over $2.5 billion in capital and we are glad they have this opportunity to share their knowledge and experience with our members this November at our Oxford University hosted Forum. The quality and originality of their insights will be intriguing to our members."